RGNX R&D to Revenue
Regenxbio Inc · R&D to Revenue
RGNX R&D to Revenue
Latest reported51.92%period ending
RGNX Quarterly R&D/Revenue (31.90% → 51.92%)
Latest values, visible window
High-resolution chart · PNG
RGNX r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 51.9223% | |
| 896.9029% | |
| 196.496% | |
| 188.6826% | |
| 260.2884% | |
| 59.6403% | |
| 237.4847% | |
| 224.9411% | |
| 201.0227% | |
| 324.3119% | |
| 231.1529% | |
| 201.2278% | |
| 299.7747% | |
| 305.7582% | |
| 199.4098% | |
| 238.8088% | |
| 186.8602% | |
| 250.3691% | |
| 12.035% | |
| 155.5097% | |
| 208.2233% | |
| 210.3474% | |
| 220.0047% | |
| 44.4516% | |
| 230.0555% | |
| 209.9014% | |
| 287.2791% | |
| 242.8027% | |
| 374.1023% | |
| 2,851.0181% | |
| 59.6635% | |
| 348.8127% | |
| 53.6734% | |
| 14.7669% | |
| 694.6078% | |
| 936.976% | |
| 212.0847% | |
| 3,652.5275% | |
| 946.875% | |
| 10,048% | |
| 449.6842% | |
| 1,573.2824% | |
| 108.354% | |
| 496.8421% | |
| 294.3507% | |
| 433.3851% | |
| 182.23% | |
| 224.6377% | |
| 54.8741% | |
| 31.9033% |